Factors affecting mortality of refractory status epilepticus
Isil Tatlidil1, Hatice S Ture2, Galip Akhan2
1Department of Neurology, Malatya Research and Training Hospital, Malatya, Turkey.
Acta Neurologica Scandinavica
|September 25, 2019
Summary
Mortality in status epilepticus (SE) is influenced by different factors depending on whether it is refractory (RSE) or not. Low Glasgow Coma Score, intubation, and hypotension predict mortality in RSE and general SE patients.
Area of Science:
- Neurology
- Critical Care Medicine
- Intensive Care
Background:
- Status epilepticus (SE) is a neurological emergency with varying mortality rates.
- Refractory status epilepticus (RSE) presents unique challenges in management and outcomes.
- Understanding mortality predictors is crucial for improving patient care in SE.
Purpose of the Study:
- To identify factors associated with mortality in refractory status epilepticus (RSE) compared to non-refractory status epilepticus (non-RSE).
- To determine independent predictors of mortality in SE patients.
Main Methods:
- Retrospective analysis of 109 status epilepticus cases from a neurological intensive care unit.
- Categorization of clinical data to identify mortality-related factors.
- Statistical analysis including multivariate analysis to detect independent predictors.
Main Results:
- Elderly age, continuous seizures, new-onset seizures, infection, prolonged ICU stay, anesthesia, and cardiac comorbidity were linked to mortality in RSE.
- Potentially fatal comorbidities were associated with mortality in non-RSE.
- Low Glasgow Coma Score (GCS ≤ 8), intubation, and hypotension were independent predictors of mortality in the overall SE population and RSE subgroup.
Conclusions:
- Low GCS, intubation, and hypotension are key indicators of increased mortality risk in SE patients.
- While overall mortality rates may be similar, the specific factors contributing to death differ between RSE and non-RSE.
- Clinicians should be vigilant for these predictors to manage SE patients effectively.
Keywords:
demographicsfactorsmortalitynon-refractory status epilepticusrefractory status epilepticusstatus epilepticusMore Related Videos
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
684
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
684
Epilepsy and Seizures: Overview
1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Acute Respiratory Failure-III
801
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
801
Acute Respiratory Failure-II
1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Acute Respiratory Failure-IV
521
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
521
Acute Respiratory Failure-I
883
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
883


